查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1708180

細菌和病毒樣本採集市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Bacterial and Viral Specimen Collection Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 138 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球細菌和病毒樣本採集市場規模達 246 億美元，預計 2025 年至 2034 年期間的複合年成長率為 13.9%。樣本採集是診斷細菌和病毒感染的關鍵步驟，涉及從患者或環境來源採集體液、組織和拭子等生物材料。隨著全球傳染病的流行不斷升級，對有效、及時的診斷方法的需求正在迅速成長。全球各地的醫療保健系統對準確的標本採集流程的需求日益成長，以促進早期診斷、更好的治療結果和有效的疾病管理。

細菌和病毒樣本採集市場 - IMG1

醫療診斷技術的進步，加上人們對早期疾病檢測的認知不斷提高，正在推動市場成長。此外，政府對醫療基礎設施和診斷創新的投資不斷增加，加上新興傳染病（包括潛在的大流行病）的持續威脅，進一步加速了對先進標本採集工具的需求。隨著對預防性醫療保健和早期檢測的日益重視，醫院、診斷實驗室和研究機構正在採用高效的標本採集試劑盒來提高診斷準確性和臨床結果。新型病原體的不斷出現以及全球對更好地預防傳染病爆發的努力也在推動市場走向新的高度，從而加強了對先進標本採集技術的需求。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 246億美元
預測值 894億美元
複合年成長率 13.9%

市場按產品類型細分，包括拭子、細菌運輸介質、採血試劑盒和其他相關產品。其中，拭子在2024年創造了92億美元的收入，成為領先的產品領域。拭子由於其簡單、方便和非侵入性而仍然受到高度青睞，在臨床和非臨床環境中使用時只需極少的培訓。它們能夠從鼻腔和喉嚨等敏感區域採集樣本，同時減少患者的不適，使其成為大規模測試和診斷的理想選擇。隨著醫療保健提供者尋求更方便用戶使用和高效的診斷解決方案，預計拭子在整個預測期內將保持強勁的需求。

從應用角度來看，細菌和病毒標本採集市場主要分為診斷和研究。診斷領域在 2024 年佔了 75.2% 的市場佔有率，預計到 2034 年將達到 665 億美元。對先進診斷工具進行準確病原體識別的日益依賴，對於確保適當的治療計劃和降低誤診風險起著至關重要的作用。隨著診斷技術的不斷創新，該領域在解決日益加重的傳染病負擔方面仍然發揮關鍵作用，並將在未來幾年實現持續成長。

從地區來看，北美細菌和病毒標本採集市場在 2024 年創造了 100 億美元的產值，這得益於美國傳染病病例的增加以及對尖端標本採集試劑盒開發的大力支持。雖然該地區實行嚴格的監管框架，但醫療保健解決方案的持續進步和強大的研發計劃正在推動整個北美市場的擴張。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 傳染病發生率上升
      • 對準確診斷的需求日益成長
      • 診斷技術的進步
      • 預防保健意識不斷提高
    • 產業陷阱與挑戰
      • 污染風險高
      • 缺乏標準化協議
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：按產品，2021 年至 2034 年

  • 主要趨勢
  • 拭子
    • 鼻拭子
    • 咽拭子
    • 其他拭子
  • 細菌運輸培養基
  • 血液採集套件
  • 其他產品

第6章：市場估計與預測：按應用，2021 年至 2034 年

  • 主要趨勢
  • 診斷
  • 研究

第7章：市場估計與預測：按適應症，2021 年至 2034 年

  • 主要趨勢
  • 細菌感染
    • 結核
    • 肺炎
    • 霍亂
    • 沙門氏菌
    • 性傳染感染（STI）
    • 其他細菌感染
  • 病毒感染
    • 流感
    • 新冠肺炎
    • 愛滋病
    • B型肝炎
    • 登革熱
    • 寨卡病毒
    • 其他病毒感染

第8章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 診斷實驗室
  • 家庭檢測
  • 其他最終用途

第9章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • Becton, Dickinson And Company
  • BIOMÉRIEUX
  • COPAN Italia
  • DiaSorinGroup
  • Hardy Diagnostics
  • HiMedia Laboratories
  • Longhorn Vaccines and Diagnostics
  • Medical Wire & Equipment
  • Puritan Medical Products
  • Pretium Packaging
  • Quidel Corporation
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Vircell SL
  • Wuxi Nest Biotechnology
簡介目錄
Product Code: 13315

The Global Bacterial and Viral Specimen Collection Market generated USD 24.6 billion in 2024 and is projected to grow at a CAGR of 13.9% between 2025 and 2034. Specimen collection is a crucial step in diagnosing bacterial and viral infections, involving the collection of biological materials such as fluids, tissues, and swabs from patients or environmental sources. As the prevalence of infectious diseases continues to escalate worldwide, the demand for effective and timely diagnostic methods is growing rapidly. Healthcare systems across the globe are witnessing an increased need for accurate specimen collection processes to facilitate early diagnosis, better treatment outcomes, and effective disease management.

Bacterial and Viral Specimen Collection Market - IMG1

Technological advancements in healthcare diagnostics, coupled with the growing awareness regarding early disease detection, are fueling market growth. Moreover, rising government investments in healthcare infrastructure and diagnostic innovations, along with the persistent threat of emerging infectious diseases, including potential pandemics, are further accelerating the demand for advanced specimen collection tools. With an increasing focus on preventive healthcare and early detection, hospitals, diagnostic labs, and research institutions are adopting highly efficient specimen collection kits to improve diagnostic accuracy and clinical outcomes. The continuous emergence of novel pathogens and the global push for better preparedness against infectious outbreaks are also driving the market to new heights, reinforcing the need for advanced specimen collection techniques.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$24.6 Billion
Forecast Value$89.4 Billion
CAGR13.9%

The market is segmented by product types, including swabs, bacterial transport media, blood collection kits, and other related products. Among these, swabs generated USD 9.2 billion in revenue in 2024, emerging as the leading product segment. Swabs remain highly preferred due to their simplicity, convenience, and non-invasive nature, requiring minimal training for use in both clinical and non-clinical environments. Their ability to collect samples from sensitive areas like the nasal cavity and throat with reduced patient discomfort makes them an ideal choice for large-scale testing and diagnostics. As healthcare providers seek more user-friendly and efficient diagnostic solutions, swabs are anticipated to maintain robust demand throughout the forecast period.

From an application perspective, the bacterial and viral specimen collection market is primarily classified into diagnostics and research. The diagnostics segment accounted for a dominant 75.2% market share in 2024 and is projected to reach USD 66.5 billion by 2034. The growing reliance on advanced diagnostic tools for accurate pathogen identification plays a vital role in ensuring appropriate treatment plans and reducing risks of misdiagnosis. With continuous innovations in diagnostic technologies, this segment remains pivotal in addressing the rising burden of infectious diseases and is set to witness sustained growth in the coming years.

Regionally, the North America bacterial and viral specimen collection market generated USD 10 billion in 2024, driven by an increasing number of infectious disease cases in the U.S. and robust support for the development of cutting-edge specimen collection kits. While the region operates under a stringent regulatory framework, consistent advancements in healthcare solutions and strong R&D initiatives are fueling market expansion across North America.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of infectious diseases
      • 3.2.1.2 Growing need for accurate diagnostics
      • 3.2.1.3 Advancements in diagnostic technologies
      • 3.2.1.4 Rising awareness of preventive healthcare
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High risk of contamination
      • 3.2.2.2 Lack of standardized protocols
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Swabs
    • 5.2.1 Nasal swabs
    • 5.2.2 Throat swabs
    • 5.2.3 Other swabs
  • 5.3 Bacterial transport media
  • 5.4 Blood collection kits
  • 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Diagnostics
  • 6.3 Research

Chapter 7 Market Estimates and Forecast, By Indication, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Bacterial infection
    • 7.2.1 Tuberculosis
    • 7.2.2 Pneumonia
    • 7.2.3 Cholera
    • 7.2.4 Salmonella
    • 7.2.5 Sexually transmitted infections (STIs)
    • 7.2.6 Other bacterial infections
  • 7.3 Viral infection
    • 7.3.1 Influenza
    • 7.3.2 COVID-19
    • 7.3.3 HIV
    • 7.3.4 Hepatitis B
    • 7.3.5 Dengue
    • 7.3.6 Zika virus
    • 7.3.7 Other viral infections

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Diagnostic laboratories
  • 8.4 Home testing
  • 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Becton, Dickinson And Company
  • 10.2 BIOMÉRIEUX
  • 10.3 COPAN Italia
  • 10.4 DiaSorinGroup
  • 10.5 Hardy Diagnostics
  • 10.6 HiMedia Laboratories
  • 10.7 Longhorn Vaccines and Diagnostics
  • 10.8 Medical Wire & Equipment
  • 10.9 Puritan Medical Products
  • 10.10 Pretium Packaging
  • 10.11 Quidel Corporation
  • 10.12 Thermo Fisher Scientific
  • 10.13 Trinity Biotech
  • 10.14 Vircell S.L.
  • 10.15 Wuxi Nest Biotechnology